Johnson & Johnson
Change company Symbol lookup
Select an option...
JNJ Johnson & Johnson
GTY Getty Realty Corp
FCX Freeport-McMoRan Inc
EFX Equifax Inc
CHKP Check Point Software Technologies Ltd
CTXS Citrix Systems Inc
RAKR Rainmaker Worldwide Inc
CLB Core Laboratories NV
KERN Akerna Corp
T AT&T Inc
Go

Health Care : Pharmaceuticals | Large Cap Value
Company profile

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Price
Delayed
$145.13
Day's Change
1.19 (0.83%)
Bid
--
Ask
--
B/A Size
--
Day's High
145.35
Day's Low
144.16
Volume
(Light)

Today's volume of 1,320,796 shares is on pace to be much lighter than JNJ's 10-day average volume of 6,538,150 shares.

1,320,796

JNJ's position in the Pharmaceuticals industry

Industry PeersJNJMRKRETAPBHZGNX

Summary

Company ProfileJohnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments...
Merck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. It operates through...
Go to MRK summary
Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing product candidates that modulate the activity of...
Go to RETA summary
Prestige Consumer Healthcare Inc., formerly Prestige Brands Holdings, Inc. is engaged in the marketing, sales and distribution of over-the-counter healthcare products. The Company operates through...
Go to PBH summary
Zogenix, Inc. is a pharmaceutical company engaged in developing and commercializing central nervous system (CNS) therapies that address specific clinical needs for people living with orphan and other...
Go to ZGNX summary
52-Week Change

VS. INDUSTRY
12.43%
-7.63%
-37.18%
-3.28%
-52.27%
Market Cap

VS. INDUSTRY
$378.9B
$197.5B
$3.8B
$1.7B
$1.1B
Beta

VS. INDUSTRY
0.7
0.4
1.7
0.7
1.8
Dividend Yield

VS. INDUSTRY
2.81%
3.13%
--
--
--
P/E (TTM, GAAP)

VS. INDUSTRY
23.03x
18.92x
--
11.42x
--
Data as of

Fundamentals

Total Revenue (TTM)

VS. INDUSTRY
$80.9B
$47.2B
$15.3M
$960.3M
$4.9M
Profit Margin

VS. INDUSTRY
20.64%
22.35%
-2,237.15%
15.84%
-8,758.48%
Earnings Growth
(5 year, GAAP)

VS. INDUSTRY
-0.24%
-1.06%
--
13.37%
--
Revenue Growth (TTM)

VS. INDUSTRY
-1.04%
6.37%
-47.52%
0.66%
354.63%
Data as of
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Copyright © 2020. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.